News
05-15-2009, 04:12 AM
At some point during their care, more than one-third of metastatic breast cancer patients receive chemotherapy off label, the legal use of FDA-approved drugs in a different indication than for which they were approved, according to researchers at The University of Texas M. D. Anderson Cancer Center.
More... (http://www.medicalnewstoday.com/articles/150121.php)
More... (http://www.medicalnewstoday.com/articles/150121.php)